IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 233 filers reported holding IMMUNOVANT INC in Q4 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $416,434 | +90.0% | 15,774 | +11.6% | 0.00% | 0.0% |
| Q1 2024 | $219,218 | -67.0% | 14,134 | -10.4% | 0.00% | 0.0% |
| Q4 2023 | $664,559 | +9.7% | 15,774 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $605,564 | +108.5% | 15,774 | +3.0% | 0.00% | 0.0% |
| Q2 2023 | $290,507 | +32.5% | 15,314 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $219,218 | -12.6% | 14,134 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $250,879 | +217.6% | 14,134 | 0.0% | 0.00% | – |
| Q3 2022 | $79,000 | +43.6% | 14,134 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -29.5% | 14,134 | +0.1% | 0.00% | – |
| Q1 2022 | $78,000 | -35.0% | 14,124 | 0.0% | 0.00% | – |
| Q4 2021 | $120,000 | -0.8% | 14,124 | +1.2% | 0.00% | – |
| Q3 2021 | $121,000 | -18.2% | 13,962 | 0.0% | 0.00% | – |
| Q2 2021 | $148,000 | -31.5% | 13,962 | +3.9% | 0.00% | – |
| Q1 2021 | $216,000 | -65.2% | 13,436 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $621,000 | +176.0% | 13,436 | +110.1% | 0.00% | 0.0% |
| Q3 2020 | $225,000 | – | 6,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,000,200 | $26,072,000 | 5.92% |
| MANGROVE PARTNERS IM, LLC | 1,139,900 | $9,906,000 | 0.89% |
| Eventide Asset Management | 4,950,000 | $43,016,000 | 0.57% |
| Ghost Tree Capital, LLC | 200,000 | $1,738,000 | 0.51% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,221,000 | 0.47% |
| FRAZIER MANAGEMENT LLC | 585,759 | $5,090,000 | 0.41% |
| MANGROVE PARTNERS IM, LLC | 500,000 | $4,345,000 | 0.39% |
| EcoR1 Capital, LLC | 1,140,819 | $9,914,000 | 0.34% |
| BCK CAPITAL MANAGEMENT LP | 53,459 | $465,000 | 0.28% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 555,065 | $4,824,000 | 0.14% |